Private equity firm Veritas Capital is exploring a sale of Cotiviti Corp that could secure a valuation of over $15 billion for the healthcare analytics company, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.
The firm had earlier been considering an IPO of Cotiviti, but is now weighing a sale due to a bout of volatility in the stock market, the report said.
Veritas declined to comment on the report.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
An official sales process could start as soon as January, the report added.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Source: Reuters
Can’t stop reading? Read more
Silver Lake and P2 Capital weigh $5bn+ sale or IPO of Blackhawk Network amid payments sector M&A surge
Silver Lake and P2 Capital weigh $5bn+ sale or IPO of Blackhawk Network amid payments sector...
Apollo exits OLB with €1.7bn sale to Crédit Mutuel, achieving rare success in German banking sector
Apollo exits OLB with €1.7bn sale to Crédit Mutuel, achieving rare success in German banking...
Top private equity news of the week
Top private equity news of the week Harvard University is advancing plans to sell approximately...